# Imagene AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imagene-ai

- Industry: Biotechnology
- Headquarters: Miami Beach, US
- Website: www.imagene-ai.com
- Latest round: Seed (May 2, 2022)
- Investors on record: 1

## About

Based in Florida, US, and founded in 2020 by Dean Bitan, Jonathan Zalach, and Shahar Porat, Imagene AI Ltd., offers molecular screening for research and clinical practice. In May 2022, Imagene AI Ltd. raised an undisclosed amount of series A funding led by an individual investor, with participation from other individual investors. In July 2025, Imagene AI Ltd. raised USD 23 million in series B funding led by new investor Oracle Venture Fund. The firm offers AI-based molecular biomarkers and genomic detection which provide real-time insights from the biopsy image. The company’s molecular and micro-environment platform can scan patients' histological data for personalized therapy. Additionally, the company helps in the drug development process and optimizing the patient’s treatment plan. The company will use the funding to enhance its foundation models, expand its digital pathology platform, and scale strategic collaborations for real-time clinical trial support and patient identification.

## Funding rounds

- Seed, May 2, 2022 — Blumberg Capital

## Investors

- Blumberg Capital (https://capitalatlas.ai/funds/blumberg-capital) — Seed